Hyaluronic Acid: Ingredient Traceability and Origin Transparency

---

Abstract

Hyaluronic acid (HA) is a glycosaminoglycan widely distributed in the connective tissues of living organisms. Since its entry into the health food and cosmetics markets in the late twentieth century, questions surrounding the sourcing of HA raw materials, manufacturing processes, and supply chain transparency have become central concerns shared by regulators, academics, and consumers alike. This paper takes an ingredient traceability perspective to systematically examine the physical forms of HA raw materials, the principal manufacturing processes, the supply chain structure of the market, and the practical criteria consumers can use to assess the credibility of product information. No claims regarding medical efficacy are made herein.

---

1. Chemical Nature and Ingredient Forms of Hyaluronic Acid

Hyaluronic acid is a linear polysaccharide composed of alternating units of D-glucuronic acid and N-acetyl-D-glucosamine. Its chemical structure is highly conserved across both animal-derived and microbially fermented sources — a structural identity that provides the scientific basis for the interchangeability of materials from different origins in industrial production.

In the commercial ingredient market, HA is broadly categorized into three molecular weight ranges:

• High molecular weight HA: typically ≥1,000 kDa; predominantly used in cosmetic raw materials
• Medium molecular weight HA: 200–999 kDa; the most widely used range across industrial applications
• Low molecular weight HA / oligomeric hyaluronic acid: <50 kDa; listed as a distinct grade by some food ingredient suppliers

Molecular weight directly affects the physical properties of the raw material — including viscosity and water solubility — but molecular weight is not in itself equivalent to any physiological effect. When reading product labels, consumers should treat molecular weight as a raw material specification parameter, not as an indicator of efficacy.

---

2. Ingredient Source Pathways: Animal Extraction and Microbial Fermentation

2.1 Animal Tissue Extraction (Traditional Pathway)

Hyaluronic acid was first isolated and characterized in 1934 by the American scientist Karl Meyer from the vitreous humor of bovine eyes. For several decades thereafter, industrial production relied primarily on extraction from rooster combs (cock's comb) — one of the richest natural animal sources of HA, with dry-weight concentrations reaching approximately 7,500 mg/100 g.

The supply chain nodes for the animal extraction pathway are: poultry farm → slaughterhouse → raw material extraction facility → purification and refining → finished ingredient. Within this chain, veterinary inspection records, certificates of origin, and batch traceability documentation are the three critical document categories for assessing raw material compliance.

The principal supply chain risks associated with animal-derived raw materials include:

• 1. Supply disruption caused by animal disease outbreaks (e.g., avian influenza);
• 2. Batch-to-batch variability in molecular weight distribution;
• 3. Risk of residual protein content exceeding specification limits, with correspondingly stricter labeling obligations for consumers with protein sensitivities;
• 4. Considerable difficulty in achieving Halal or Kosher certification.

2.2 Microbial Fermentation (Mainstream Pathway)

Beginning in the 1990s, microbial fermentation using *Streptococcus zooepidemicus* as the host strain progressively displaced animal extraction to become the dominant pathway for industrial HA production worldwide. From the 2000s onward, some manufacturers moved further toward engineered strains of non-animal origin — such as *Bacillus subtilis* — to entirely eliminate the risk of animal pathogen carryover and to meet vegan certification requirements.

The fermentation pathway features a more concentrated set of supply chain nodes: carbon and nitrogen source supply (typically glucose, corn steep liquor, and other agricultural commodities) → master cell bank management → fermentation → extraction and purification (precipitation, ultrafiltration, ion exchange, and related unit operations) → drying → finished ingredient.

Compared with animal extraction, the fermentation pathway offers higher traceability across the following dimensions:

• Strain origin is documented and a strain identification report can be provided;
• Batch-to-batch molecular weight distribution is more uniform;
• Residual protein levels are generally lower and purification processes are more readily standardized;
• The agricultural origin of carbon source raw materials can be independently traced.

---

3. Fermentation Process Flow and Quality Control Key Points

For a compliant batch of fermentation-derived HA raw material, the quality control documentation chain typically encompasses the following stages:

(1) Origin and Purity of Carbon and Nitrogen Sources

The country of origin of principal carbon sources such as glucose, pesticide residue test reports, and non-GMO declarations (where applicable) represent the starting point of ingredient-level traceability documentation.

(2) Strain Batch Records

These document the strain's source institution, identification number, number of passages, and pathogenicity test results. For *Streptococcus zooepidemicus* strains in particular, a certificate confirming the absence of streptococcal toxin residues (such as streptolysin) is required.

(3) Fermentation Process Parameter Records

These include critical process parameters such as temperature, pH, dissolved oxygen, and culture duration, along with records of in-process sampling and testing.

(4) Certificate of Analysis (CoA) for the Purified Raw Material

A compliant release CoA should include at minimum: HA content (%), molecular weight (by viscometry or weight-average method), moisture, ash, heavy metals (lead, arsenic, mercury, cadmium), microbial limits (total aerobic plate count, mold, yeast), and residual protein.

(5) Supplier Audits and GMP Certification

GMP (Good Manufacturing Practice) certification at the raw material supplier level is the primary basis on which finished product manufacturers conduct supplier qualification and management. finished product manufacturers procuring HA raw materials typically require suppliers to provide third-party certification or to undergo periodic on-site audits.

---

4. Japan's Hyaluronic Acid Ingredient Supply Chain Landscape

Japan is one of the world's significant producers and consumers of HA raw materials. From an industry structure perspective, there is a well-defined division of labor between raw material manufacturing and finished product manufacturing.

On the supply side, Japan is home to a number of established HA raw material producers, some of which have accumulated fermentation process expertise and proprietary strains dating back to the 1980s. These raw material manufacturers typically supply downstream finished product manufacturers in the cosmetics, food, and health food sectors. Ingredient specifications and quality documentation are drawn up in accordance with guidelines from Japan's Food Safety Commission and the Ministry of Health, Labour and Welfare (MHLW).

On the finished product side, GMP management in Japan's health food sector is primarily implemented through the GMP Compliance Accreditation Program of the Japan Health and Nutrition Food Association (JHNFA), a public interest foundation. This accreditation program establishes explicit requirements for incoming raw material inspection, warehouse management, production process controls, and finished product release. Accredited facilities are subject to periodic document reviews and on-site inspections. JHNFA GMP accreditation constitutes an important benchmark for assessing manufacturing compliance within Japan's domestic health food sector, as the entire production workflow at accredited sites is governed by the documentation requirements of the certification scheme.

From an import perspective, mainland China is also the world's largest exporter of HA raw materials, with several large-scale fermentation manufacturers. importers typically require suppliers to provide test data compliant with Japan's Food Sanitation Act and the Standards for Food Additives, and imported materials are subject to sampling inspection by the MHLW at the port of entry.

---

5. Origin Transparency and Supply Chain Traceability Standards

5.1 Core Elements of "Origin Transparency"

In the health food context, "ingredient origin transparency" is not simply a matter of printing a country name on the packaging. It constitutes a comprehensive information disclosure framework that typically encompasses:

• Country of origin declaration for raw materials: clearly identifying the country where the HA raw material was produced — not merely the country where the product was packaged or the finished product manufactured;
• Disclosure of manufacturing process pathway: distinguishing between animal-derived and fermentation-derived origin, and specifying the animal-origin status of the fermentation strain used;
• Accessibility of third-party test reports: whether consumers or downstream purchasers can obtain batch-specific Certificates of Analysis (CoAs);
• Verifiability of certification marks: any GMP, organic, or non-GMO certification marks shown on the product can be independently verified through the certifying body's official website or accreditation number.

5.2 Information Asymmetry and Label Interpretation

Japan's current Health Promotion Act and Act against Unjustifiable Premiums and Misleading Representations specify mandatory disclosure items for health food labeling, but the "country of origin of raw materials" is not a universally mandatory disclosure requirement across all product categories. As a result, the market contains products that carry only the notation "Manufactured in Japan" without disclosing the origin of the raw materials used. "Manufactured in Japan" indicates that the finished product underwent final processing within Japan — it does not mean that the ingredients used were produced in Japan.

When reading hyaluronic acid product labels, consumers should pay particular attention to the following:

---

6. Molecular Weight Labeling and Information Transparency

Molecular weight is one of the most important specification parameters for HA raw materials and is also the area where the greatest disparities in labeling transparency are observed across the industry.

High molecular weight and low molecular weight/oligomeric hyaluronic acid differ fundamentally in their physicochemical properties, yet some product labels refer only generically to "hyaluronic acid" without stating a molecular weight range, leaving consumers unable to determine whether the ingredient corresponds to the specifications used in the literature they may have encountered.

Responsible ingredient transparency should include:

• Stating the molecular weight range of the HA used (in kDa), either on the label or on the product page;
• If multiple molecular weight grades of HA are present in the formulation, listing the content of each grade individually;
• Disclosing the molecular weight measurement method (e.g., gel permeation chromatography (GPC) or viscometry).

---

7. Actionable Guidance for Consumers

The following are practical information verification steps consumers can take when selecting and evaluating hyaluronic acid health food products:

Step 1: Confirm the completeness of daily intake information

Product labels should clearly state the serving size, number of servings per day, and daily HA content in milligrams. A product that omits the daily content figure has a fundamental gap in information transparency.

Step 2: Verify the validity of GMP certification

If a product states JHNFA GMP Compliance Accreditation, visit the JHNFA official website and enter the accreditation number (typically a five-digit format) in the GMP Certified Facility Directory to confirm that the accreditation is currently valid and covers HA-related product categories.

Step 3: Inquire about the ingredient sourcing pathway

Contact the manufacturer's customer service channel to ask: whether the HA raw material is animal-derived or fermentation-derived; if fermentation-derived, whether the strain is of animal origin; and which country the raw material was produced in. A responsible manufacturer should generally be able to respond to these questions in writing within a reasonable timeframe.

Step 4: Request the third-party Certificate of Analysis

Ask the manufacturer for the CoA for the relevant raw material batch. Focus on whether the heavy metal testing panel covers lead, arsenic, mercury, and cadmium, and whether the testing laboratory holds ISO/IEC 17025 accreditation.

Step 5: Distinguish between marketing language and verifiable facts

When product promotional materials use terms such as "hydration," "moisturization," or "joint lubrication," be aware of the restrictions that law places on permissible labeling for health foods. Foods with Health Claims — including Foods for Specified Health Uses (FOSHU), Foods with Nutrient Function Claims (FNFC), and Foods with Function Claims (FFC) — are subject to strict approval or notification procedures before any functional claims may be stated. Ordinary foods may not in any form imply medical or physiological effects. Any promotional language that exceeds these regulatory boundaries warrants a careful and critical reading.

---

Conclusion

The traceability and transparency of hyaluronic acid raw materials serve as a microcosm of the information integrity standards prevailing in the health food industry. From the evolution of animal extraction to microbial fermentation, and from batch test reports to established GMP certification frameworks, documented and verifiable information exists at every node of the supply chain. Consumers have both the right and the practical ability to verify this information through publicly available channels, rather than relying solely on self-declarations on product packaging.

In an era of increasingly accessible information, manufacturers that proactively disclose ingredient origin, manufacturing process pathway, test data, and certification numbers demonstrate a level of transparency that is itself a meaningful signal of product credibility. Conversely, products that avoid making these disclosures warrant a commensurately higher degree of scrutiny.

Supply chain traceability is not a marketing label. It is an objective reflection of supply chain management quality.

---

*This paper has been compiled on the basis of publicly available materials and applicable regulations in Japan's health food industry. All statements are limited to verifiable factual dimensions concerning raw material ingredients, manufacturing processes, labeling, and certification. Nothing herein constitutes medical advice, nor does it evaluate the efficacy of any specific product.*